Roux-en-Y gastric bypass vs sleeve gastrectomy in super obesity: a systematic review and meta-analysis

© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) are safe procedures that may present sub-optimal results in superobesity (SO). A meta-analysis was pe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Obesity surgery 2022-01, Vol.32 (1), p.170-185
Hauptverfasser: Gomes-Rocha, Sofia Raquel, Costa-Pinho, André Manuel, Pais-Neto, Carolina Coelho, de Araújo Pereira, André, Nogueiro, Jorge Pedro Martins, Carneiro, Silvestre Porfírio Ramos, Santos-Sousa, Hugo Miguel Teixeira Ferraz, Lima-da-Costa, Eduardo Jorge, Bouça-Machado, Raquel, Preto, John Rodrigues
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 Laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG) are safe procedures that may present sub-optimal results in superobesity (SO). A meta-analysis was performed aiming to summarize the available evidence on weight loss (primary outcome) and comorbidities resolution of LRYGB and LSG in patients with SO (BMI ≥ 50 kg/m2). From the 16 included studies, 7 integrated the meta-analysis. LRYGB showed a significantly higher weight loss at 6 to 12-months, but not after 24 months and a higher dyslipidemia resolution at 12 months. When compared with LSG, LRYGB achieved better weight loss after 6 and 12 months and higher dyslipidemia resolution after 1 year. There were no significant differences for resolution of the other co-morbidities studied.
ISSN:0960-8923
1708-0428
1708-0428
DOI:10.1007/s11695-021-05745-8